2Greenspon PJ ,Saklofske DH. Toward an integration of subjective well being and psyehopathology[J]. Soeia Indie Res,2001,51(1): 81-108.
3Kashani JH. Psychiatric disorders in a community sample of adolescents[J]. Am J Psychiatry. 1987, 14(4):584.
4Myers JK. Six- month prevalence of psychiatric disorders in three communities [J]. Arch Gen Psychiatry, 1984, 4 ( 1 ):959.
5Satoh S. Depression in members of a new religious sect in Japan[J]. The Japanese Journal of Psyehiatry and Neurology,1990, 44(3), 541-549.
6Blumental MD. Measuring depression sympto-matology in a general population[J]. Arch Gen Psychiatry, 1975, 3(2) :971-978.
7Pardon M C, Ma S, Morilak D A. Chronic cold stress sensitizes brain noradrenergic reactivity and noradrenergic facilitation of the HPA stress response in Wistar Kyoto rats[J]. Brain Res, 2003, 971 (1): 55- 65.
8Jentsch J D, Roth R H, Taylor J R. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drag action[J]. Prog Brain Res, 2000, 126:433- 453.
9Kent J M, Mathew S J, Gorman J M. Molecular targets in the treatment of anxiety[J]. Biol Psychiatry, 2002, 52(10): 1008- 1030.
8Sails AD, Barrett A, Sarginson S, et. al. Molecular epidemiology of Mycobacterium tuberculosis in East Lancashire 2001 -2009 [J]. Thorax, 2011,66(8) :709 -713.
9Dawson R, Narunsky K, Carman D, et al. Two-stage activity- safety study of daily rifapentine during intensive phase treatment of pulmonarytuberculosis [ J ]. Int J Tuberc Lung Dis, 2015,19 ( 7 ) : 780 - 786.
10Roberts-Witteveen A, Reinten T, Christensen A, et. al. Multi- drug-resistant tuberculosis in New South Wales, Australia, 1999- 2010: a case series report[J]. Int J Tuberc Lung Dis,2015 ,19 (7) :850 -856.
